Delivery Order SPE2DB25D3306-SPE2DB25FUCHD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,830 to AmerisourceBergen Drug Corp for SKYRIZI 180 mg/1.2 ml on-body injectors on September 25, 2025, with an ultimate completion date of October 17, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors valued at $11,830.00. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to complete by September 18, 2025, with performance executed from AmerisourceBergen's Conshohocken, Pennsylvania headquarters. This delivery order...
- The Defense Logistics Agency awarded a $11,830 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of SKYRIZI 180 MG/1.2 ML on-body injectors with a completion deadline of October 15, 2025. SKYRIZI is a biologic medication used in the treatment of immune-mediated inflammatory diseases. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $23,660 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The company,...
- The Defense Logistics Agency awarded a $11,830 delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a $11,830 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors. The contract, which carries an ultimate completion date of September 29, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $11,830.00 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 180 mg/1.2 ml on-body injectors on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed price contract represents a competitively awarded, non-set-aside procurement of the pharmaceutical product to support federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $25,209.26 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body injectors on April 29, 2025, with a completion date of May 20, 2025. This firm fixed price, non-set-aside contract was issued under a competitive procurement process and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic treatment used for dermatological conditions, representing part of the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 26, 2025, for the supply of SKYRIZI 180 mg/1.2 mL on-body injectors valued at $11,830.00. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The contract will be completed by August 15, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic...
- The Defense Logistics Agency awarded a delivery order valued at $78,225.51 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The place of performance is listed as...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCHDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 180 mg/1.2 ml on-body injectors, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania. SKYRIZI is a biologic medication used to treat inflammatory skin conditions, reflecting AmerisourceBergen's critical role as a major pharmaceutical distributor supporting military and federal healthcare systems. As a leading healthcare solutions provider, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. The comprehensive IDC vehicle enables flexible ordering of pharmaceutical products to support military healthcare programs worldwide, positioning AmerisourceBergen as a key vendor in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 7/22/25 |